QVT Financial LP 13D and 13G filings for Roivant Sciences Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:00 pm Sale |
2024-12-31 | 13G | Roivant Sciences Ltd. ROIV |
QVT Financial LP | 65,793,779 9.220% |
-926,000 (-1.39%) |
Filing |
| 2024-03-07 5:33 pm Sale |
2024-03-07 | 13G | Roivant Sciences Ltd. ROIV |
QVT Financial LP | 66,719,779 8.280% |
-45,821,757 (-40.72%) |
Filing |
| 2024-02-14 11:14 am Sale |
2023-12-31 | 13G | Roivant Sciences Ltd. ROIV |
QVT Financial LP | 112,541,536 13.970% |
-10,000,000 (-8.16%) |
Filing |
| 2023-02-14 11:46 am Sale |
2022-12-31 | 13G | Roivant Sciences Ltd. ROIV |
QVT Financial LP | 122,541,536 16.890% |
-6,852,281 (-5.30%) |
Filing |
| 2022-02-14 3:00 pm Purchase |
2021-12-31 | 13G | Roivant Sciences Ltd. ROIV |
QVT Financial LP | 129,393,817 18.700% |
129,393,817 (New Position) |
Filing |